IL6 and breast carcinoma: Moreover, breast cancer-derived exosomes are capable of inducing IL-6 secretion and a pro-tumoral phenotype (IL-6, IL-10, CCL2 production) in macrophages, partially via gp130/STAT3 signaling [106].